Ikarian Capital’s scPharmaceuticals SCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-18,647
|
|
||||
|
2023
Q3 | $133K | Sell |
18,647
-131,353
|
|
||||
|
2023
Q2 | $1.53M | Buy |
+150,000
|
|
||||
|
2022
Q4 | – | Sell |
-479,383
|
|
||||
|
2022
Q3 | $3.13M | Sell |
479,383
-404,625
|
|
||||
|
2022
Q2 | $4.26M | Sell |
884,008
-86,090
|
|
||||
|
2022
Q1 | $5.51M | Buy |
970,098
+68,736
|
|
||||
|
2021
Q4 | $4.53M | Hold |
901,362
|
|
||||
|
2021
Q3 | $5.99M | Sell |
901,362
-193,662
|
|
||||
|
2021
Q2 | $6.69M | Sell |
1,095,024
-213,675
|
|
||||
|
2021
Q1 | $8.7M | Sell |
1,308,699
-157,448
|
|
||||
|
2020
Q4 | $7.76M | Sell |
1,466,147
-15,000
|
|
||||
|
2020
Q3 | $11M | Buy |
1,481,147
+12,500
|
|
||||
|
2020
Q2 | $10.8M | Buy |
1,468,647
+395,000
|
|
||||
|
2020
Q1 | $7.95M | Buy |
+1,073,647
|
|